A perspective on improving the R-CHOP regimen: from Mega-CHOP to ROBUST R-CHOP, the PHOENIX is yet to rise

Lue, JK; O'Connor, OA

Lue, JK (corresponding author), Columbia Univ, Dept Med, Irving Med Ctr, Ctr Lymphoid Malignancies,Div Hematol Oncol, New York, NY 10032 USA.

LANCET HAEMATOLOGY, 2020; 7 (11): E838

Abstract

The integration of rituximab (R) into cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) by Coiffier and colleagues was the first, and ......

Full Text Link